4E2RCat
目录号: PL09356 纯度: ≥98.0%
CAS No. :432499-63-3
商品编号 规格 价格 会员价 是否有货 数量
PL09356-1mg 1mg ¥1360.00 请登录
PL09356-5mg 5mg ¥4080.00 请登录
PL09356-10mg 10mg ¥6181.82 请登录
PL09356-50mg 50mg ¥18545.45 请登录
PL09356-100mg 100mg ¥25963.64 请登录
PL09356-200mg 200mg 询价 询价
PL09356-500mg 500mg 询价 询价
PL09356-10mM*1mLinDMSO 10mM*1mLinDMSO ¥4092.36 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
4E2RCat
中文别名
4E2RCat
英文名称
4E2RCat
英文别名
4E2RCat;5-[5-[(Z)-(3-benzyl-4-oxo-2-thioxo-thiazolidin-5-ylidene)methyl]-2-furyl]-2-chloro-benzoic acid;Benzoic acid, 2-chloro-5-[5-[(Z)-[3-phenylmethyl-4-oxo-2-thioxo-5-thiazolidinylidene]methyl]-2-furanyl]-
Cas No.
432499-63-3
分子式
C22H14ClNO4S2
分子量
455.93
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
4E2RCat是eIF4E-eIF4G相互作用的抑制剂,IC50值为13.5 μM。
生物活性
4E2RCat is an inhibitor of eIF4E-eIF4G interaction with an IC 50 of 13.5 μM.
性状
Solid
IC50 & Target[1][2]
IC50: 13.5 μM (eIF4E-eIF4G)
体外研究(In Vitro)
4E2RCat prevents the interaction between eIF4E (the cap-binding protein) and eIF4G (a large scaffolding protein), inhibiting cap-dependent translation. It significantly decreases human coronavirus 229E (HCoV-229E) replication, reducing the percentage of infected cells and intra- and extracellular infectious virus titers. 4E2RCat inhibits cap-dependent translation in a dose-dependent manner. 4E2RCat inhibits cap-dependent FF translation but not EMCV IRES-driven Ren translation. 4E2RCat inhibits coronavirus replication in a dose- and time-dependent manner. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
4E2RCat inhibits protein synthesis in vivo and it is not a consequence of increased cell death. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Cencic R, et al. Blocking eIF4E-eIF4G interaction as a strategy to impair coronavirus replication. J Virol. 2011 Jul;85(13):6381-9.
溶解度数据
In Vitro: DMSO : 23.33 mg/mL (51.17 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2